Heyuan Biotech Obtains Medical Device Registration Certificate

Warm Congratulations! Our Company’s Medical Recombinant Collagen Gynecological Gel Awarded Medical Device Registration Certificate

Recently, Wuhan Heyuan Biotechnology Co., Ltd. has received the Medical Device Registration Certificate of the People’s Republic of China issued by the Hubei Provincial Medical Products Administration (Registration Certificate No.: E Medical Device Approval 20252185862). This marks that the independently developed Medical Recombinant Collagen Gynecological Gel has officially passed national authoritative certification and been approved for market launch!

The newly approved Medical Recombinant Collagen Gynecological Gel is another core achievement of our company in the women’s health sector, specially designed for female private part health protection.

Product Structure: The product consists of two parts: gel and applicator. The core ingredient of the gel is recombinant collagen, matched with isomaltose oligosaccharide, glycerin, carboxymethyl chitosan and other ingredients. The applicator is made of medical-grade polypropylene, safe and convenient, and is a disposable product.

Application Scope: It forms a protective gel membrane on the vaginal wall to physically isolate the vaginal wall from external bacteria, thereby preventing the colonization of pathogenic microorganisms and providing reliable physical protection for women’s private part health.

Specifications: Available in multiple specifications: 2.0g/unit, 2.5g/unit, 3.0g/unit, 3.5g/unit, 4.0g/unit, 4.5g/unit and 5.0g/unit, meeting the usage needs of different scenarios.

Since the project initiation, the company’s R&D team has always promoted product development with high standards and strict requirements. After multiple key stages including formula optimization, process verification, quality control and clinical evaluation, the product successfully passed the review and approval and obtained the medical device registration certificate.

The approval of this registration certificate is not only an authoritative recognition of our company’s R&D strength, production capacity and quality management system by regulatory authorities, but also marks that the product matrix of Heyuan Biotechnology in the women’s health sector has been further improved, laying a solid foundation for the subsequent market promotion and clinical application of products.

Moving forward, Wuhan Heyuan Biotechnology Co., Ltd. will continue to uphold the philosophy of “Technology Safeguards Women’s Health, Innovation Leads a Quality Life”. We will continue to deepen our presence in the women’s health field, repay the society with safer and more effective compliant products, and provide professional and reliable health solutions for the majority of women.

Wuhan Heyuan Biotechnology Co., Ltd.

November 12, 2025